MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cea.13972

Медицинская библиотека · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021

Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.

Margaritte-Jeannin Patricia, Budu-Aggrey Ashley, Ege Markus, Madore Anne-Marie, Linhard Christophe, Mohamdi Hamida, von Mutius Erika, Granell Raquel, Demenais Florence, Laprise Catherine, Bouzigon Emmanuelle, Dizier Marie-Hélène

СтатьяМетаанализПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Numerous genes have been associated with the three most common allergic diseases (asthma, allergic rhinitis or eczema) but these genes explain only a part of the heritability. In the vast majority of genetic studies, complex phenotypes such as co-morbidity of two of these diseases, have not been considered. This may partly explain missing heritability.

OBJECTIVE

To identify genetic variants specifically associated with the co-morbidity of asthma-plus-eczema.

METHODS

We first conducted a meta-analysis of four GWAS (Genome-Wide Association Study) of the combined asthma-plus-eczema phenotype (total of 8807 European-ancestry subjects of whom 1208 subjects had both asthma and eczema). To assess whether the association with SNP(s) was specific to the co-morbidity, we also conducted a meta-analysis of homogeneity test of association according to disease status ("asthma-plus-eczema" vs. the presence of only one disease "asthma only or eczema only"). We then used a joint test by combining the two test statistics from the co-morbidity-SNP association and the phenotypic heterogeneity of SNP effect meta-analyses.

RESULTS

Seven SNPs were detected for specific association to the asthma-plus-eczema co-morbidity, two with significant and five with suggestive evidence using the joint test after correction for multiple testing. The two significant SNPs are located in the OCA2 gene (Oculocutaneous Albinism II), a new locus never detected for significant evidence of association with any allergic disease. This gene is a promising candidate gene, because of its link to skin and lung diseases, and to epithelial barrier and immune mechanisms.

CONCLUSION

Our study underlines the importance of studying sub-phenotypes as co-morbidities to detect new susceptibility genes.

Для цитирования: Margaritte-Jeannin Patricia, Budu-Aggrey Ashley, Ege Markus, Madore Anne-Marie, Linhard Christophe, Mohamdi Hamida, von Mutius Erika, Granell Raquel, Demenais Florence, Laprise Catherine, Bouzigon Emmanuelle, Dizier Marie-Hélène. Identification of OCA2 as a novel locus for the co-morbidity of asthma-plus-eczema.. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 2021. DOI: 10.1111/cea.13972.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.